Gritstone Oncology, Inc. (GRTS): Price and Financial Metrics
GRTS Price/Volume Stats
| Current price | $0.03 | 52-week high | $3.17 |
| Prev. close | $0.05 | 52-week low | $0.03 |
| Day low | $0.03 | Volume | 61,017,900 |
| Day high | $0.04 | Avg. volume | 7,014,435 |
| 50-day MA | $0.40 | Dividend yield | N/A |
| 200-day MA | $1.17 | Market Cap | 3.50M |
GRTS Stock Price Chart Interactive Chart >
Gritstone Oncology, Inc. (GRTS) Company Bio
Gritstone Oncology, Inc., an immuno-oncology company, engages in developing personalized cancer immunotherapies for various cancer types in the United States. It is developing GRANITE-001, a personalized immunotherapy product for cancer patients; and SLATE-001 for patients with common tumor neoantigens. The company was founded in 2015 and is based in Emeryville, California.
GRTS Price Returns
| 1-mo | N/A |
| 3-mo | -93.96% |
| 6-mo | -96.26% |
| 1-year | -97.73% |
| 3-year | -99.71% |
| 5-year | -99.64% |
| YTD | -98.53% |
| 2023 | -40.87% |
| 2022 | -73.17% |
| 2021 | 226.40% |
| 2020 | -56.08% |
| 2019 | -41.94% |
Continue Researching GRTS
Here are a few links from around the web to help you further your research on Gritstone Oncology Inc's stock as an investment opportunity:Gritstone Oncology Inc (GRTS) Stock Price | Nasdaq
Gritstone Oncology Inc (GRTS) Stock Quote, History and News - Yahoo Finance
Gritstone Oncology Inc (GRTS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...